Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,609.50
Bid: 1,609.00
Ask: 1,610.00
Change: -2.50 (-0.16%)
Spread: 1.00 (0.062%)
Open: 1,607.50
High: 1,610.50
Low: 1,594.00
Prev. Close: 1,612.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Santarus, Sequenom, Durect, Tremor, Gap

Fri, 08th Nov 2013 12:44

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Nov 8 (Reuters) - U.S. stock index futures advanced onFriday, indicating the S&P 500 will rebound from its biggestdaily decline since late August, ahead of a key report on thelabor market. S&P 500 futures was up 3.6 points, DowJones industrial average futures was up 11 points andNasdaq 100 futures was up 12 points.

** TWITTER INC, Thursday close $44.90, up 0.8 pctpremarket

The micro-blogging site's shares jumped 73 percent in afrenzied trading debut that drove the seven-year-old company'smarket value to around $25 billion and evoked the heady days ofthe dot-com bubble.

** SANTARUS INC, Thursday close $, up 37 pct aftermarket

** SALIX PHARMACEUTICALS LTD, Thursday close$71.31, up 9.3 pct after market

Salix said it will buy Santarus for about $2.6 billion,gaining two new gastroenterology drugs to strengthen its leadingpresence in that market.

** SEQUENOM INC, Thursday close $1.70, up 23 pctafter market

The genetic testing company reported a smaller-than-expectedthird-quarter loss on Thursday due to higher sales of itsprenatal test designed to detect fetal chromosomalabnormalities.

** DURECT CORP, Thursday close $1.54, down 20percent after market

The drugmaker said it is offering shares in an underwrittenpublic offering. The company had about 102 million sharesoutstanding as of Thursday.

** INSULET CORP, Thursday close $37.05, down 8 pctafter market

The medical device maker reported a muchbigger-than-expected third-quarter loss on Thursday as operatingexpenses rose due to the settlement of a patent lawsuit withMedtronic Inc and the launch of a version of its insulinmanagement system OmniPod.

** PRICELINE.COM INC, Thursday close $1022.89, up1.6 pct premarket

The online travel agency known for its name-your-own priceauction, posted a higher-than-expected quarterly profit onThursday as bookings increased.

** TREMOR VIDEO INC, Thursday close $9.26, down 30pct after market

The online video advertising provider reportedlower-than-expected third-quarter results on Thursday and cutits revenue forecast for 2013. Canaccord Genuitycuts its rating on the stock to "hold" from "buy" and its pricetarget by $3.50 to $9.

* CHEMOCENTRYX INC, Thursday close $4.67, up 7 pctpremarket

The company reported a smaller-than-expected quarterly lossdue to lower expenses and higher revenue from its partnerGlaxoSmithKline Plc, which is funding Chemocentryx drugto treat a disease that causes inflammation of blood vessels inthe kidney.

** WALT DISNEY CO, Thursday close $67.15

The company reported a 12 percent gain in profit that beatWall Street expectations, lifted by higher visitor spending atU.S. theme parks, increased consumer product sales and itssummer animated movie hit "Monsters University." Shares ofDisney, which have gained nearly 35 percent this year, slipped1.8 percent in after-hours trading to $65.94.

** MOLYCORP INC, Thursday close $4.76

The rare earths producer has seen demand and prices for itsproducts rise from their second-quarter lows, the company'schief executive said on Thursday, although the company reporteda wider third-quarter loss.

** BLACKBERRY LTD , Thursday close $6.5

The company will pay its new interim CEO a base salary of $1million, a bonus of up to twice that amount as well as stockawards potentially worth some $85 million, in the hopes ofturning around Canada's most prominent technology company.

** COCA-COLA CO, Thursday close $40.05

The company said it will invest over $4 billion in China andbuild new plants between 2015 and 2017, to counter competitionwhich is chipping away at its share of the country's 421 billionyuan ($69.12 billion) soft drinks market.

** PIXELWORKS INC, Thursday close $4.39, down 8.8pct after market

The digital display chip maker's third-quarter results camein below analysts' expectations on Thursday due to lower chiprevenue.

** GROUPON INC,Thursday close $9.50, up 1.3 pctpremarket

The daily coupon website reported a third-quarter profitthat beat analysts' estimates as strong growth in North Americahelped offset a decline in international revenue.

** SPROUTS FARMERS MARKET INC, Thursday close$46.58, down 4.8 pct after market

The retailer of natural and organic foods on Thursday saidaffiliates of Apollo Global Management LLC, and certain otherstockholders, will sell up to 22.5 million shares in a secondaryoffering.

** AMARIN CORP, Thursday close $1.41, up 6.3 pctafter market

The drugmaker reported a smaller-than-expected third-quarterloss on Thursday as sales of its fish-oil drug Vascepa, whichlowers a type of blood fat, jumped 52 percent from the secondquarter. Total prescriptions for Vascepa were up 58 percent fromthe preceding quarter, Amarin said in a statement.

** FIREEYE INC, Thursday close $38.03, up 9 pctafter market

The technology firm that helps companies fend off cyberattacks, gave a revenue outlook for 2014 that came in ahead ofWall Street forecasts as it posted results for the first timesince it went public in September in one of this year's hottestIPOs.

** GAP INC, Thursday close $37.75, up 8 pct aftermarket

The apparel chain's October same-store sales rose 4 percent,well ahead of the analysts' average estimate of 0.1 percent.

** ARENA PHARMACEUTICALS INC, Thursday close $4.08,up 5 pct after market

The company said Japanese drugmaker Eisai Co Ltd will market its diet drug in most markets worldwide as part ofan expanded agreement, under which the companies will alsodevelop the drug for other indications.

** TALISMAN ENERGY INC Thursday close $11.71

The company said it would sell a stake in some ofits natural gas assets in British Columbia's Montney field toMalaysia-controlled Progress Energy Canada Ltd for C$1.5 billion($1.44 billion) as it restructures global operations.

** JOHNSON & JOHNSON, Thursday close $92.69

Healthcare conglomerate Danaher Corp DHR.N has teamed upwith Blackstone Group LP BX.N to bid for the company'sdiagnostics unit, which makes blood screening equipment andlaboratory blood tests and could fetch more than $4 billion,according to people familiar with the matter.

** NVIDIA CORP, Thursday close $14.54, up 2 pctafter market

The graphics chipmaker gave a revenue forecast for thecurrent quarter that was shy of Wall Street's expectations asthe company faces tough competition in tablets and a slowpersonal computer market.

** GENCO SHIPPING AND TRADING LTD, Thursday close$2.66, down 2.2 pct after market

Analysts at Wells Fargo Securities said the dry bulkshipper, which has short-term debt of $1.5 billion, was likelyto breach its debt agreements. "It remains increasingly unlikelythat Genco Shipping will be able to maintain covenant compliancethrough March 31, 2014," analyst Michael Webber said.

** COSTA INC, Thursday close $19.98

Essilor International said it would buy Costa, amaker of premium sport sunglasses, in a $270 million deal thatwould help the French company tap into the growing prescriptionsun lens market.

(Compiled by Natalie Grover; Editing by Don Sebastian)

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.